Atlas Trials

Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia

Clinical trial NCT00034801 · COMPLETED

Trial details

NCT number
NCT00034801
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
DepressionSchizophreniaSchizoaffective Disorder
Start date
2001-09-01
Enrollment
378

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.